November 21, 2011
A study using genetically modified zebrafish to visualize early events involved in development of human atherosclerosis describes an efficient model – one that the researchers say offers many applications for testing the potential effectiveness of new antioxidant and dietary therapies.
July 27, 2020
Researchers at Ludwig Institute for Cancer Research and University of California San Diego School of Medicine report that inhibiting a key enzyme caused human cancer cells associated with two major types of breast and ovarian cancer to die and in mouse studies reduced tumor growth.
May 25, 2012
Five scientists from the University of California, San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine (CIRM) to conduct stem cell-based research into regenerating spinal cord injuries, repairing gene mutations that cause amyotrophic lateral sclerosis and…
June 13, 2024
This month, NASA astronaut Kate Rubins ‘99 visited UC San Diego to participate in a panel discussion alongside renowned leaders in space technology and health. The symposium offered insights into how research conducted in space can be translated into applications that keep humans healthy on earth.
June 2, 2014
The Health Data Exploration project, from the University of California, San Diego (UC San Diego) and the University of California, Irvine (UCI), has been awarded a $1.9 million grant from the Robert Wood Johnson Foundation (RWJF), to create a network of researchers, scientists, companies and others to catalyze the use…
March 14, 2024
From flies to humans, there are many types lipids operating at once. Now, a team led by UC San Diego bioengineers presents what they believe is the first method for distinguishing multiple lipid subtypes in cells and tissue samples by using nondestructive label-free optical imaging methods.
September 13, 2018
…discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis (NASH), a chronic and aggressive liver condition. By identifying caspase-2’s critical role, they believe an inhibitor of this enzyme could provide an effective way to stop the pathogenic progression that leads…
March 14, 2022
The U.S. Agency for International Development has funded a $38 million, five-year project led by UC San Diego researchers to better understand and promote health agency for individuals, communities and local organizations in low- and middle-income countries.
February 24, 2021
UC San Diego School of Medicine researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems. Their findings may help explain the wide variety in COVID-19 symptoms and aid the search for therapies.
July 21, 2016
In an effort to expand the number of cancer gene mutations that can be specifically targeted with personalized therapies, researchers at University of California San Diego School of Medicine and Moores Cancer Center looked for combinations of mutated genes and drugs that together kill cancer cells. The study, published July…
